Replicate Bioscience, Inc.

Replicate Bioscience, Inc.

Biotechnology 10210 Campus Point Dr 21 employees
Employees
21
Contacts
3
Emails
3
Phones
2

Replicate Bioscience, Inc. Overview

Headquarters
10210 Campus Point Dr
Industry
Biotechnology
Employees
21
Founded
2020
Funding
40.0M
Company Email
Available in AeroLeads
Keywords

About Replicate Bioscience, Inc.

Replicate Bioscience is amplifying the power of RNA therapeutics by pioneering novel self-replicating RNA (srRNA) technology. Replicate’s off-the-shelf srRNAs contain two components: virally derived genetic code to drive controlled and self-limiting amplification, and the RNA encoding therapeutic proteins. Our library of viral vectors, selected for driving robust and sustained protein expression and orders-of-magnitude improved performance over linear mRNA, allow for the development of treatments in applications including oncology, infectious disease, and autoimmunity. Differentiated by a team of srRNA experts, a customizable library of synthetic srRNA vectors, and end-to-end development capabilities, Replicate is uniquely positioned to finally expand the reach of RNA treatments toward widespread use in infectious disease, immuno-oncology, autoimmune disease, and more.

Replicate Bioscience, Inc. Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage
Phone contacts
2
50.0% coverage

Replicate Bioscience, Inc. Org Chart

Sample employees and titles
Name Title Contact
Christian Maine, Ph.d. Drug Development - Clinical Translation
View
Christine Domingo Senior Scientist at Replicate
Email Phone
Hunter Little Scientist at Replicate Bioscience
Email
Herbert Kim Lyerly Co-founder at Replicate Bioscience, Inc.
Email Phone

Employees by Management Level

Senior / Lead 3 profiles
Individual contributor 3 profiles
Executive 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 4 4 1
Operations 1 1 1

Replicate Bioscience, Inc. Tech Stack

Data / AI 4 profiles

Compare Similar Companies to Replicate Bioscience, Inc.